Melisron (MLSR) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Melisron ILS 120, price ILS 401, upside -70.2%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Melisron for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
54‑month range 186.60 ILA – 471.52 ILA · fair‑value band 119.64 ILA – 331.59 ILA · the 400.90 ILA price screens above the 119.64 ILA fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow Melisron in your weekly email
Every Wednesday you see whether Melisron is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Melisron Ltd. operates as a commercial real estate company in Israel. It operates through Income Producing Real Estate and Residential Development and Construction segments.
Show more
Melisron Ltd. operates as a commercial real estate company in Israel. It operates through Income Producing Real Estate and Residential Development and Construction segments. The company engages in the purchase, construction, operation, rental, management, maintenance, and improvement of commercial centers, including regional, urban and neighbourhood malls and shopping centers; development, construction, owning, maintenance, and management of office complexes and hi-tech parks; residential development and construction, and urban renewal projects. It also owns and manages single-tenant properties and housing complexes. The company's shopping centers serve as shopping, leisure, and entertainment centers. Melisron Ltd. was incorporated in 1987 and is based in Herzliya Pituach, Israel.
Stock analysis
Melisron (MLSR) currently trades at 400.90 ILA, while our model-based Fair Value estimate is 119.64 ILA, implying the stock looks roughly 235.1% overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 336.76 ILA per share, and 2 of the 16 models we run sit above the 400.90 ILA price.
Bear case: the Growth DCF group reads lowest at 20.86 ILA, and 14 of the 16 models stay below the price. Evidence for this calculation is high.
Scenario range: 119.64 ILA (bear) to 331.59 ILA (bull), the price of 400.90 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Real Estate sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Melisron reported revenue of 2.3B ILS in FY2025 versus 1.4B ILS in FY2021, a compound +12.3%/yr. Reported net income was 1.9B ILS in FY2025, compounding +6.0%/yr from FY2021.
Key figures
Market cap 19.1B ILA · P/E ratio 10.2 · P/S ratio 8.34 · EPS (TTM) 39.39 ILA · Dividend yield 1.4% · Net margin 81.9% · Return on equity 14.7% · Return on assets (EBIT) 7.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −37% fair-value upside, at −70%, MLSR screens richer than that median.
Fair Value models
Bear 119.64 ILAFair Value 119.64 ILABull 331.59 ILA
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (24.67 ILS per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+12.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.2%
Start year 2020 (pandemic). Over 10 years: +6.0% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+7.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.6%
Dividend (yield on the price)1.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6% vs 10%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−4% → 65%
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+45.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +43.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 546 stocks
Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score54 · Below median
Fair Value upside−68% · Bottom 25%
Profitability
Return on equity (TTM)15% · Top 25%
Return on assets3% · Above median
Net margin (TTM)79% · Top 25%
Operating margin (TTM)63% · Top 25%
Growth and dividend
Revenue growth11% · Above median
Dividend yield (TTM)1.4% · Bottom 25%
Balance sheet
Debt / equity0.99× · Highest 25%
Valuation Multiplesvs Real Estate Services median · lower = cheaper
P/E (TTM)10.2× · Cheaper than median
P/B0.48× · Cheaper than median
P/S (TTM)2.63× · Pricier than median
P/FCF22.5× · Priciest 25%
EV/EBITDA11.6× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 37
FUTURE (revenue growth)56· sector 12
PAST (return on equity)59· sector 16
HEALTH (low debt)50· sector 83
DIVIDEND (yield)28· sector 64
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Melisron Fair Value". https://www.fairvalue-calculator.com/stock/MLSR
Frequently asked questions
Is Melisron (MLSR) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 119.64 ILA versus a price of 400.90 ILA, about −70% upside (overvalued).
What is the fair value of MLSR?
Our model-based fair value for Melisron is 119.64 ILA (as of Sep 24, 2026), built from audited fundamentals. The current price: 400.90 ILA.
What is the quality score of MLSR?
Melisron has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Melisron (MLSR)?
Our model-based price target is the fair value of 119.64 ILA (as of Sep 24, 2026) from 16 valuation models. Cautious scenario 119.64 ILA, optimistic scenario 331.59 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Melisron stock forecast for 2026?
Our models put fair value at 119.64 ILA, about −70% upside versus a price of 400.90 ILA (overvalued). Cautious scenario 119.64 ILA, optimistic scenario 331.59 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Melisron (MLSR)?
Melisron reported trailing-twelve-month revenue of about 2.4B ILS (latest available figure, as of Sep 24, 2026).
Does Melisron pay a dividend?
Melisron currently shows a dividend yield of about 1.41% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Melisron (MLSR)?
For today's price to be fair in a discounted-cash-flow model, Melisron would have to grow free cash flow by +45.9 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of MLSR use?
Our models discount Melisron at 10.1 %: a base by market capitalisation (mid), damped by beta 0.40, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Melisron that is +45.9 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Melisron (MLSR) delivered so far?
Over the past 5 years revenue at Melisron grew +15.3 % a year. The price currently implies +45.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Melisron (MLSR) growing?
The median revenue growth in the sector is +1.8 % a year. That is the yardstick for the growth priced into Melisron (+45.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Melisron (MLSR)?
The free-cash-flow yield on the price is 1.46 %: that much free cash flow Melisron produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Melisron (MLSR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Melisron it is 119.64 ILA per share (as of Sep 24, 2026), against a price of 400.90 ILA. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Melisron stock overvalued or undervalued in 2026?
As of Sep 24, 2026, MLSR trades above its calculated fair value: price 400.90 ILA, fair value 119.64 ILA, a gap of about −70% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MLSR?
No. The price is what the market pays today (400.90 ILA); the fair value is what the company's own numbers justify (119.64 ILA). For Melisron the two are 281.26 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Melisron worth?
The market values Melisron at about 19.1B ILA (market capitalisation, as of Sep 24, 2026). Per share that is 400.90 ILA; our models calculate a fair value of 119.64 ILA per share.
What do the bullish and bearish scenarios say about MLSR?
Our models span a range for Melisron: cautious scenario 119.64 ILA, base 119.64 ILA, optimistic 331.59 ILA per share (as of Sep 24, 2026, price 400.90 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MLSR?
Melisron trades at a price-to-earnings ratio of 10.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 119.64 ILA is built from several models across several years. Other multiples: P/B 0.5, P/S 2.6, EV/EBITDA 11.6.
How solid is the balance sheet of Melisron (MLSR)?
Balance-sheet figures for Melisron (as of Sep 24, 2026): return on equity 14.7%, debt of 0.99 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is MLSR from its 52-week high?
Melisron trades at 400.90 ILA, about 15% below its 52-week high of 471.52 ILA and 12% above the low of 358.09 ILA (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 119.64 ILA is for.
Which stocks are comparable to Melisron?
From the same area (Real Estate) we also value Vingroup Joint Stock Company, CBRE Group, Vonovia SE, Cellnex Telecom, S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Melisron stock attractive at the current price?
The data as of Sep 24, 2026: price 400.90 ILA, calculated fair value 119.64 ILA (−70%), Quality Score 53/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MLSR calculated?
We run Melisron through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 119.64 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Melisron itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Melisron (MLSR)?
The closing price on Sep 23, 2026 was 400.90 ILA. Our model-based fair value is 119.64 ILA, about −70% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Melisron right now?
The price sits above even our optimistic bull case (331.59 ILA). The favourable scenario is already priced in. The model range is unusually wide (119.64 ILA to 331.59 ILA). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Melisron (MLSR) come from?
Earnings per share at Melisron grew +7.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share +4.1 %, EBIT margin −1.6 %, tax rate −0.7 %, residual (interest, one-offs) +5.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Melisron
How large is the market capitalisation of Melisron (MLSR)?
The market capitalisation of Melisron is 19.1B ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Melisron (MLSR)?
The price-to-sales ratio of Melisron is 8.34 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Melisron (MLSR)?
Earnings per share at Melisron are 39.39 ILA (price ÷ EPS = P/E 10.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Melisron (MLSR)?
The dividend yield of Melisron is 1.4% (payout 14.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Melisron (MLSR)?
The net margin of Melisron is 81.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Melisron (MLSR)?
The return on equity (ROE) of Melisron is 14.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Melisron (MLSR)?
On an EBIT basis the return on assets of Melisron is 7.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Melisron (MLSR)?
The operating margin of Melisron is 63.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Melisron (MLSR)?
Revenue at Melisron is growing +11.1% versus a year earlier (3y avg +10.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Melisron (MLSR)?
Earnings per share at Melisron are growing +11.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Melisron (MLSR) carry?
The net debt of Melisron is 14.2B ILA (fiscal year 2025, ≈ 50.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Melisron in the live analysis
One click puts Melisron on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
